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Background: Gene therapy is a potentially effective therapeutic modality for treating 
  sensorineural hearing loss. Nonviral gene delivery vectors are expected to become extremely safe 
and convenient, and nanoparticles are the most promising types of vectors. However,   infrequent 
nuclear localization in the cochlear cells limits their application for gene therapy. This study 
aimed to investigate the potential nuclear entry of hyperbranched polylysine   nanoparticles 
(HPNPs) for gene delivery to cochlear targets.
Methods: Rat primary cochlear cells and cochlear explants generated from newborn rats were 
treated with different concentrations of HPNPs. For the in vivo study, HPNPs were adminis-
tered to the rats’ round window membranes. Subcellular distribution of HPNPs in different cell 
populations was observed with confocal microscope 24 hours after administration.
Results: Nuclear entry was observed in various cochlear cell types in vitro and in vivo. In the 
primary cochlear cell culture, concentration-dependent internalization was observed. In the 
cochlear organotypic culture, abundant HPNPs were found in the modiolus, including the spiral 
ganglion, organ of Corti, and lateral wall tissues. In the in vivo study, a gradient distribution of 
HPNPs through different layers of the round window membrane was observed. HPNPs were 
also distributed in the cells of the middle ear tissue. Additionally, efficient internalization of 
HPNPs was observed in the organ of Corti and spiral ganglion cells. In primary cochlear cells, 
HPNPs induced higher transfection efficiency than did LipofectamineTM.
Conclusion: These results suggest that HPNPs are potentially an ideal carrier for gene delivery 
into the cochlea.
Keywords: gene therapy, hearing loss, cochlea, internalization, nanoparticles, nuclear 
localization
Introduction
Gene therapy is a potentially effective therapeutic modality for treating congenital and 
acquired hearing loss by either changing mutant genes or upregulating critical gene 
expression.1–3 Regarding the gene delivery vectors, several viral vectors, including 
adenovirus,4,5 adeno-associated virus,6–8 lentivirus,9 herpes simplex virus type 1, and 
vaccinia virus,10,11 have shown encouraging results in gene therapy. However, their use 
is accompanied by potential toxicity, immunological complications, and insertional 
mutagenesis.12,13 Such genotoxic effects can result in oncogenesis or even death.14–16 
Therefore, they are still not regarded as safe systems for inner ear gene delivery.
Consequently, nonviral gene delivery vectors are expected to be safer and more 
convenient.17 Nanoparticles are the most promising gene carriers among the nonviral 
gene delivery vectors.18,19 Potential candidate nanoparticles, lipid nanocapsules, were International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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observed to distribute in the rat cochlear cell populations after 
round window membrane permeation.20 However, infrequent 
nuclear   localization in the cochlear cells limits their applica-
tion for gene therapy. Many studies have confirmed that in 
cells with cytoplasmic   plasmid delivery mediated by nonviral 
vectors, only those with evidence of nuclear plasmid local-
ization showed efficient transgene expression.21,22 Usually, 
transfection efficiency is facilitated in dividing populations 
of cells in which the nuclear envelope disassembles during 
  mitosis, thus largely eliminating this barrier. Unfortunately, 
most cochlear cell populations, especially spiral ganglion 
cells and hair cells, which are targets for gene therapy, do not 
actively undergo cell division during the gene transfer   process, 
making gene transfer mediated by cytoplasmic   plasmid deliv-
ery difficult. Thus, nuclear plasmid delivery induced by nano-
particles may be an option to improve transgene expression 
in nondividing or growth-arrested cells.23
Cationic polymers were reported to be potential   candidate 
nonviral vectors for nuclear delivery of plasmids which 
could promote transgene delivery to the nucleus in vitro.24–26 
  Hyperbranched polylysine nanoparticles (HPNPs) are 
  dendritic polymers with imperfectly branched or irregular 
structures, which are polydispersed and can be prepared in 
a single step on a large scale. Studies of the effects of such 
polymers on nuclear internalization by cochlear cells and 
on cell toxicity are scarce. Therefore, the present study was 
designed to investigate the potential nuclear entry of HPNPs 
in cochlear cells using both in vitro and in vivo experiments 
and depict information for developing novel   nanoparticles 
suitable for gene therapy in hearing loss. Nucleolin 
  distribution in the cultivated cochlear cells was analyzed. 
  Preliminary gene transfection mediated by HPNPs was tested 
in vitro. Furthermore, the viability of L929 mouse fibroblasts 
and cochlear cells treated by HPNPs was   evaluated by 
  CellQuanti-Blue reagent (BioAssay Systems, Hayward, CA) 
and propidium iodide, respectively.
Materials and methods
synthesis of hPNPs
HPNPs were synthesized by thermal polymerization of 
L-lysine hydrochloride and labeled with fluorescent dye, 
FITC (HPNPs without FITC tagging were used for gene 
transfection). The thermal polymerization of L-lysine 
hydrochloride was performed at 150°C in the presence of an 
alkaline metal base to neutralize the amine hydrochloride and 
to create the corresponding free amino acid base according 
to the procedure described by Scholl et al.27 Samples were 
purified by dialysis and gel filtration with a Sephadex column. 
The final product was recovered with 85% yield as an orange 
powder. Before usage in vitro or in vivo, the powder was dis-
solved in phosphate-buffered saline, resulting in a molecular 
concentration of 10–3 mol/L. The molecular weight, average 
hydrodynamic diameter, and polydispersity index of the 
HPNPs were determined by dynamic light scattering (Zeta-
sizer Nano ZS, Malvern   Instruments Ltd, UK; Mn = 22,000 g/
mol, hydrodynamic diameter = 73 nm,   polydispersity 
index = 1.9). The zeta potential of   polyplexes was also 
determined by dynamic light scattering. Encapsulation effi-
ciencies of plasmid DNA were calculated indirectly from 
the amount of nonencapsulated plasmid DNA recovered in 
the supernatant samples   collected upon centrifugation of the 
nanoparticles. The amount of recovered free plasmid DNA 
in the supernatant was determined by spectrophotometry 
  (NanoDrop® ND-1000, Wilmington, DE). The encapsulation 
efficiency was calculated as the ratio of the plasmid DNA 
loaded into the HPNPs to the total amount of plasmid 
DNA used for the preparation of the original mixture. The 
physicochemical characterization of polyplexes formed by 
complexation of HPNPs and plasmid DNA is summarized in 
Table 1. The surface morphology of the HPNPs was evaluated 
by scanning electron microscopy (Zeiss ULTRAplus, Bay-
ern, Germany), which showed spherical morphology and 
similar size to the dynamic light scattering measurement 
(Figure 1).
Primary cochlear cell culture
Thirteen newborn rats (1–5 days old) were decapitated after 
deep anesthesia and sterilization with 70% ethanol. The 
cochleae were isolated and cut into small pieces and then 
dissociated with a phosphate-buffered saline-based solution 
containing elastase 1 mg/mL (Sigma Aldrich, St Louis, MO), 
collagenase type I 1 mg/mL (Sigma Aldrich), and trypsin 
Table 1 Physicochemical characteristics of hyperbranched poly-   
  lysine nanoparticles loaded with pDNA (ie, pgeneclipTM hMgFP)
HPNPs/pDNA 
(w/w)a
Mean  
hydrodynamic 
diameter (nm)
Zeta  
potential 
(mV)
PDI EE (%)
1:1 234 ± 4.6 +17.1 0.192 83.4
2:1 155 ± 2.3 +14.1 0.236 82.8
3:1 139 ± 0.9 +19.8 0.204 85.5
4:1 147 ± 3.8 +20.3 0.216 87.9
5:1 134 ± 1.0 +23.3 0.222 92.6
6:1 137 ± 18.9 +19.1 0.254 91.7
Note: aN/P (w/w) ratio of polyplexes was varied from 1:1 to 6:1 (2.5 μg plasmid 
DNA and varying amounts of hPNPs were used to prepare the polyplexes).
Abbreviations:  PDI,  polydispersity  index;  EE,  encapsulation  efficiency;  HPNPs, 
hyperbranched polylysine nanoparticles.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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0.5 mg/mL (Sigma Aldrich) for 30 minutes at 37°C. The 
digestion was terminated by adding 1 mL   DMEM-F12 (Sigma 
Aldrich) containing 10% fetal bovine serum (In  vitrogen, 
Carlsbad, CA). After centrifugation for five minutes at 
250 × g, the cell pellets were   resuspended in 1 mL of defined 
medium (DMEM-F12 with B27 supplement, 1 mM n-acetyl-
L-cysteine, 1%   penicillin–streptomycin, and 20 ng/mL epider-
mal growth factor [Sigma Aldrich]) and plated into a four-well 
  Lab-Tek®II Chamber Slide (Nalge Nunc   International, 
Naperville, IL)   containing 1.0 mL defined medium/well. 
The cells were cultured at 37°C in a CO2 incubator overnight 
and then treated with HPNPs. HPNPs in defined cell culture 
medium with different   concentrations (final   concentrations: 
3 × 10−9 mol/L, 6 × 10−9 mol/L, 1.2 × 10−8 mol/L, 2.4 × 10−8 mol/L, 
4.8 × 10−8 mol/L, 9.7 × 10−8 mol/L, 1.94 × 10−7 mol/L, 
3.87 × 10−7 mol/L, 7.74 × 10−7 mol/L, 1.55 × 10−6 
mol/L, 3.13 × 10−6 mol/L, 5 × 10−6 mol/L, 6.25 × 10−6 mol/L) 
were freshly prepared, and 1 mL of each solution was applied 
to one well of the slide. After 24 hours of cell growth under 
the same conditions, the cells were incubated in defined 
DMEM-F12 medium containing 5 μg/mL propidium iodide 
(Sigma Aldrich) for 10 minutes, which was applied to evalu-
ate the change in cell membrane permeability and to identify 
the nuclei of dying cells in a population. After washing with 
phosphate-buffered saline for 3 × 1 minutes, cells were 
fixed with 4% paraformaldehyde for 30 minutes. The nuclei 
were stained with 4’, 6-diamidino-2-phenylindole (DAPI, 
10 ng/mL; Sigma Aldrich) for 10 minutes. Cells were then 
mounted with Fluoromount™ (Sigma Aldrich) for confocal 
microscopy (phosphate-buffered saline washes for 3 × 5 min-
utes were applied between each staining step). For nucleolin 
staining, the fixed cells were washed with phosphate-buffered 
saline for 3 × 1 minutes, incubated with 0.1% Triton X-100 
for 15 minutes, preinoculated goat serum (diluted at 1:20) for 
30 minutes, rabbit antinucleolin antibody (diluted at 1:100 
with 0.1% bovine serum albumin in phosphate-buffered 
saline [Sigma Aldrich]) overnight, TRITC-conjugated 
goat   antirabbit IgG (diluted at 1:400 with 0.1% bovine 
serum albumin in phosphate-buffered saline) for 60 minutes, 
and DAPI 10 ng/mL for 10 minutes. The cells were washed 
with phosphate-buffered saline containing 0.1% Tween 20 for 
3 × 2 minutes between each step and finally mounted with 
Fluoromount for confocal microscopy. For a negative control, 
the primary antibody was replaced with 0.1% bovine serum 
albumin in phosphate-buffered saline.
cochlear organotypic culture
Five newborn rats (1–5 days old) were decapitated after deep 
anesthesia and sterilization with 70% ethanol. Similar to the 
primary cochlear cell cultures, each cochlea was isolated, 
cut into 3–4 pieces, and plated into a four-well Lab-Tek®II 
Chamber Slide (Nalge Nunc International)   containing 
1.0 mL defined medium/well. The cochlear tissues were 
cultured at 37°C in a CO2 incubator   overnight and then 
treated with HPNPs at concentrations of 2.5 × 10−6 mol/L 
and 1 × 10−5 mol/L for 24 hours. At the end of the incubation, 
the cochlear tissues were washed with phosphate-buffered 
saline 3 × 3 minutes and fixed in 4% paraformaldehyde for 
30 minutes. After washing with phosphate-buffered saline, 
a selection of the specimens were counterstained with 
TRITC-labeled phalloidin 50 μg/mL (Sigma Aldrich) for 
40 minutes, DAPI 10 ng/mL for 10 minutes, and mounted 
with Fluoromount for confocal microscopy. The rest of the 
specimens were used for Myosin VIIA staining according 
to the following procedure. The specimens were incubated 
with 0.1% Triton X-100 for 15 minutes, preinoculated 
goat serum (diluted to 1:20) for 30 minutes, rabbit anti-
Myosin VIIA antibody (diluted to 1:100 with 0.1% bovine 
serum albumin-phosphate-buffered saline) overnight, 
TRITC-conjugated goat antirabbit IgG (diluted to 1:400 
0.1% bovine serum albumin-phosphate-buffered saline) 
for 60 minutes, and DAPI 10 ng/mL for 10 minutes. The 
specimens were washed with phosphate-buffered saline 
containing 0.1% Tween 20 for 3 × 2 minutes between each 
step, and were finally mounted with Fluoromount for con-
focal microscopy.
In vivo intratympanic hPNP 
administration
Six male Sprague-Dawley rats (3–10 months old) weighing 
400–750 g with a normal Preyer’s reflex were supplied by the 
Figure 1 scanning electron micrograph of hyperbranched polylysine nanoparticles. 
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experimental animal unit, University of Tampere. All animal 
experiments were approved by the University of Tampere 
ethical committee. Animal care and experimental procedures 
were conducted in accordance with European legislation. For 
intratympanic administration of HPNPs, the animals were 
under general anesthesia (medetomidine 0.5 mg/kg, Orion 
Pharma, Finland, and ketamine 75 mg/kg, Pfizer AB, Finland, 
given intraperitoneally). After local analgesia with lidocaine, 
a retroauricular incision was used to expose the left bulla. A 
hole was drilled on the bulla with a 2 mm diameter burr. After 
visualizing the stapedial artery, the round window membrane 
was identified above the artery. A small piece of gelatin sponge 
pledget (approximately 8 mm3 after saturation) saturated with 
10−3 mol/L HPNPs was placed on the round window mem-
brane for 24 hours. The operation was performed under sterile 
conditions. Atipamezole hydrochloride 2 mg/kg was injected 
intraperitoneally immediately after the operation to accelerate 
recovery from anesthesia. Saline 2 mL was administered by 
subcutaneous injection in the neck. L-Polamivet® 0.4 mL/kg 
was injected twice a day to relieve pain. After 24 hours, fol-
lowing intraperitoneal injections of pentobarbital 60 mg/
kg, the cochleae were fixed using cardiac perfusion with 
4% paraformaldehyde, and the bullae were collected and 
further fixed for 60   minutes. The cochleae were thoroughly 
washed with tap water for 30 seconds, opened by breaking 
the bony wall under a stereomicroscope, and then washed 
again with phosphate-buffered saline for 2 × 5 minutes. The 
bullae were incubated with DAPI 10 μg/mL for 10 minutes 
to stain the nuclei. After washing with phosphate-buffered 
saline for 3 × 5 minutes, the round window membrane, sta-
pedial artery, middle ear mucosa, lateral wall, and modiolus, 
together with the basilar membrane, were harvested using a 
stereomicroscope, placed on glass slides, and mounted with 
Fluoromount for confocal microscopy.
Cytotoxicity test in mouse fibroblasts
L929 mouse fibroblasts (American Type Culture   Collection 
number CCL 1, DSMZ, Braunschweig, Germany) were 
  cultured in DMEM culture medium (AppliChem,   Darmstadt, 
Germany) containing 4.5 mg/mL glucose, 10% fetal calf 
serum, 100 U/mL penicillin G, 100 μg/mL   streptomycin 
(PAA Laboratories, Cölbe, Germany), and NaHCO3 3.7 g/L 
at 37°C, 5% CO2, and 95% humidity. Cells were harvested 
by   trypsinization (PAA Laboratories) and seeded at a 
density of 2000 cells/well into a 96-well microtiter plate 
(Greiner Bio-one, Frickenhausen, Germany). The cells 
were cultured under the above   conditions for 24 hours and 
then treated with HPNPs. HPNPs were freshly prepared 
with cell   culture medium at different concentrations (final 
concentrations were 10−4 mol/L, 10−5 mol/L, 10−6 mol/L, 
10−7 mol/L, 10−8 mol/L, 10−9 mol/L, 10−10 mol/L, 10−11 mol/L, 
10−12 mol/L, 10−13 mol/L), and 200 μL of each solution was 
applied to one well of the microtiter plate. After 48 hours 
of incubation, the medium containing HPNPs was replaced 
by fresh medium containing 10% CellQuanti-Blue reagent, 
and the cells were cultivated for another two hours. Cellular 
reductase activity was quantified by resorufin fluorescence 
(Fluostar Optima, BMG, Offenburg, Germany; excitation 
wavelength 544 nm, emission wavelength 590 nm). Cel-
lular uptake of FITC-tagged HPNPs was quantified by cell 
fluorescence measurements (excitation wavelength 485 nm, 
emission wavelength 520 nm).
Preliminary hPNP-mediated  
gene transfection
We purchased the plasmid pGeneClipTM hMGFP, which 
encodes a shRNA to silence the inhibitor of differentiation 
and DNA binding-2 (Id2) transiently, and express the reporter 
gene EGFP (SuperArray, Bioscience Corp, Frederick, MD). 
NIH 3T3 cells (American Type Culture Collection, Manassas, 
VA) were cultured in flasks containing DMEM (Sigma 
Aldrich) supplemented with 10% fetal bovine serum 
(Invitrogen) and 4 mM L-glutamine (Sigma Aldrich). Four 
hours before transfection, the cells are trypsinized and 
replated into 12-well plates at a density of 3.5 × 105 cells per 
well in 1 mL of fresh medium. For each well to be transfected, 
2.5 μg plasmid DNA and varying amounts of HPNPs 
(N/P (w/w) ratios of polyplexes varied from 1:1 to 6:1) were 
added separately to 50 μL of 150 mM NaCl. Prior to addition 
to the culture, HPNP solution was added to the plasmid 
DNA solution and allowed to stand at room temperature for 
10 minutes. At four hours after transfection, another 1 mL 
fresh medium was added to the well, and the cells were 
incubated as before. Cochlear cells were also transfected 
with the pGeneClip hMGFP plasmid using HPNPs at an 
N/P (w/w) ratio of 5:1 and Lipofectamine 2000 (Invitrogen), 
respectively. Lipofectamine-mediated transfection was 
performed according to the manufacturer’s instructions. 
After 24 hours of transfection, the cells were fixed using 
4% paraformaldehyde. The nuclei were counterstained with 
DAPI for 10 minutes. Finally, the cells were mounted with 
Fluoromount for confocal microscopy.
confocal microscopy
The specimens were observed under an Olympus IX70   
microscope with ANDOR IQ installed. The excitation filters International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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were 488 nm (blue excitation) and 568 nm (green   excitation), 
and an Ar-Kr laser was used as the excitation source. The 
corresponding emission filters were 525/50 (FITC) and 
607/45 (TRITC). DAPI was excited with a 340–380 nm filter 
and detected using a 500 LP filter. The signal intensity was 
analyzed with Image J software.
statistical analysis
Cells expressing green fluorescent protein were counted 
as positive cells and cells with DAPI-counterstained 
nuclei were defined as total number of cells (104 cells 
were counted) using Image J software. Transfection 
efficiencies were calculated by dividing the number of 
green fluorescent protein positive-cells by the total number 
of cells. The signal intensity was corrected by the intensity 
of a randomly selected background region. The corrected 
mean values were analyzed with the SPSS program (v. 11.5, 
Chicago, IL). Differences in the levels of signal intensity 
among concentrations and cell populations were analyzed by 
analysis of variance. P , 0.05 was accepted as an indication 
of statistical significance.
Results
Internalization of hPNPs in primary 
cochlear cells
After 24 hours of incubation, efficient internalization of 
HPNPs was observed in primary rat cochlear cell cultures at 
all tested concentrations. The amount of HPNPs internalized 
by the cells was dosage-dependent, which means that the 
higher concentration of HPNPs applied to the medium, the 
greater the fluorescent intensity in the cochlear cells. This 
positive correlation was statistically significant (P , 0.001, 
analysis of variance, Figure 2). Nuclear entry of HPNPs was 
detected in different types of cochlear cells, including the 
hair cells and spiral ganglion cells at different concentrations 
(Figures 3–5). The higher the concentration of HPNPs, 
the more nuclear localization was observed (Figure 3). 
In the cochlear cells that were incubated with HPNPs at 
concentrations from 3.87 × 10−7 mol/L to 6.25 × 10−6 mol/L, 
homogenous and condensed distribution of HPNPs was 
detected in the entire nuclei (Figures 4 and 5). Nuclear 
permeation of propidium iodide, which indicates cell death, 
was also observed in cochlear cells treated with HPNPs at 
concentrations from 3.87 × 10−7 mol/L to 6.25 × 10−6 mol/L 
(Figures 4 and 5). In the outer hair cells, condensed 
distribution of HPNPs was visualized in the upper part of 
the cell body including cuticular plates, and nuclei. HPNP 
vesicles appeared in the hair bundles (Figures 5A–C). 
In the inner hair cells, cytoplasmic vesicles and condensed 
homogenous nuclear distribution of HPNPs were observed 
(Figures 5D–F). HPNPs were included in both cytoplasmic 
and nuclear vesicles when the cochlear cells were treated 
with HPNPs at concentrations below 3.87 × 10−7 mol/L 
(Figure 3). No permeation of propidium iodide was 
detected in the nuclei when the HPNPs concentration was 
lower than 3.87 × 10−7 mol/L, indicating that these cells 
were alive. Furthermore, the HPNP vesicles also indicate 
active nuclear entry of HPNPs into living cells instead of 
passive diffusion of HPNPs into the nuclei of dead cells in 
which homogenous and condensed distribution of HPNPs 
was detected in the entire nuclei (Figures 4G–I). However, 
nuclear permeation of propidium iodide was occasionally 
observed in spiral ganglion cells treated with HPNPs at a 
concentration of 9.7 × 10−8 mol/L (Figures 5G–I). Scarce 
perinuclear distribution of propidium iodide dots, together 
with HPNP vesicles, was observed in the cochlear cells 
(Figure 3B). Interestingly, nuclei compressed by HPNP 
vesicles and permeated with propidium iodide were also 
observed (Figures 5J–M). Nucleolin expression was detected 
in the cochlear cells. The subcellular distribution of nucleolin 
was in both the cytoplasm and nucleus (Figure 6). In the 
nucleus, most nucleolin was localized and condensed in 
the nucleolus. A HPNP vesicle pathway from the cytoplasm 
towards the nucleolin-positive nucleolus was also observed 
(Figure 6). Nucleolin was not detected in the negative control 
specimens.
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hPNPs internalization in rat cochlear 
organotypic culture
In cochlear organotypic culture treated with HPNPs for 
24 hours, abundant HPNPs appeared in diverse cell types of 
the modiolus, organ of Corti, and the lateral wall (Figure 7). 
The hair cell region was demonstrated by Myosin VIIA 
staining (Figures 7A and B). Nuclear entry of HPNPs was 
frequently observed in these different cell types.
hPNPs in adult rat cochlear cells after 
round window membrane permeation
HPNPs were observed in the round window membrane, 
middle ear mucosa, organ of Corti, spiral ganglion, stria 
vascularis, spiral ligament, and stapedial artery cells at 
24 hours after round window membrane administration. 
HPNPs appeared in both layers of the round window 
membrane (Figure 8A). Homogenous condensed distribu-
tion of HPNPs was detected in the nuclei, and   cytosolic 
Figure 3 hPNP vesicle formation in both the cytoplasm and nuclei was observed at concentrations below 3.87 × 10−7 mol/L [A) 3.87 × 10−7 mol/L, B) 1.94 × 10−7 mol/L, 
C) 9.7 × 10−8 mol/L, D) 4.8 × 10−8 mol/L, E) 2.4 × 10−8 mol/L, F) 1.2 × 10−8 mol/L, G) 6 × 10−9 mol/L, and H) 3 × 10−9 mol/L]. Nuclear permeation of propidium iodide was 
not detected in these cells. Perinuclear distribution of dot-like propidium iodide vesicle was observed in B (arrow).
Notes: green: FITc-conjugated hPNPs. red: propidium iodide permeation. Blue: nuclear staining by DAPI. scale bar = 5 μm.
Abbreviation: hPNPs, hyperbranched polylysine nanoparticles.
HPNP vesicles were traveling from the outer layer 
towards the inner layer (Figure 8A). Additionally, there 
was a gradient of cytosolic HPNP vesicles from the outer 
layer to the inner layer (  Figure 8A). More pronounced 
nuclear entry was also observed in the outer layer of the 
round window membrane than in the inner layer. In the 
middle ear mucosal cells, HPNPs were observed in both 
the cytoplasm and nuclei (  Figure 8B). The distribution 
was condensed in the nuclei, and there was a very small 
amount of vesicles in the   cytoplasm. In the spiral gan-
glion cells, perinuclear distribution of HPNP vesicles 
was observed (Figure 8C). In the organ of Corti, HPNPs 
were detected in the cytoplasm of outer hair cells, inner 
hair cells, and supporting cells (Figure 8D). In the stria 
vascularis, HPNP vesicles appeared in the tight junctions, 
cytoplasm, and perinuclear region of the marginal cells 
(Figure 8E). In the spiral ligament fibrocytes, HPNPs 
mainly appeared in the   cytoplasm as vesicles (  Figure 8F). 
Abundant HPNPs were also detected in the stapedial artery International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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cells and appeared as vesicles in both the cytoplasm and 
nuclei (Figure 8G).
cytotoxicity of hPNPs in L929 cells
HPNPs at concentrations up to 10−7 mol/L were not toxic 
to L929 cells (Figure 9). However, higher concentrations 
of HPNPs showed low cytotoxicity, yielding an ED50 of 
10−6.2 mol/L. HPNPs labeled with FITC were visualized 
inside cells by confocal microscopy. The amount of HPNPs 
internalized by the cells was dosage-dependent, which 
was consistent with the results from the primary cochlear 
cells. The cell death rate was correlated with the HPNP 
internalization rate at concentrations up to 10−5 mol/L.
hPNPs-mediated transfection of the 
pgeneclip hMgFP plasmid in vitro
After 24 hours of incubation, NIH 3T3 cells were transfected 
with the pGeneClip hMGFP plasmid using HPNPs. 
To determine the optimum N/P (w/w) ratio, the N/P (w/w) 
ratio was varied from 1:1 to 6:1. N/P (w/w) ratios of 4:1 
and 5:1 resulted in the maximal level of green fluorescent 
protein expression. HPNP-mediated transfection efficiency 
in NIH 3T3 cells was 29.8% at an N/P (w/w) ratio of 5:1 
(Figure 10A). HPNP-mediated transfection efficiency in 
primary cochlear cell culture was 8.7% at an N/P (w/w) 
ratio of 5:1 (Figure 10B), which was higher than the 
Lipofectamine-mediated transfection efficiency of 6.0% 
(Figure 10C).
Discussion
The success of nonviral gene therapy has been largely 
  limited by inefficient gene delivery to cochlear cells due to 
the presence of the nuclear envelope barrier to gene transfer. 
The primary intention of this study was to demonstrate the 
potential of HPNPs as carriers for the delivery of genes to 
the nuclei of cochlear cells. Although it has been shown 
Figure 4 Internalization of hPNP-induced permeation of propidium iodide in primary cochlear cell culture. A–C) The cochlear cells were incubated with hPNPs at a 
concentration of 6.25 × 10−6 mol/L. B) Nuclear permeation of propidium iodide was observed in all the tested cells. C) shows the merged images of A and B. D–F) The 
cochlear cells were incubated with hPNPs at a concentration of 3.87 × 10−7 mol/L. E) Nuclear permeation of propidium iodide was observed in most of the cells.   
F) shows the merged images of D and E. G–I) Internalization of HPNP-induced permeation of propidium iodide in a single cell (higher magnification) at a concentration of 
6.25 × 10−6 mol/L. G) homogenous and condensed distribution of hPNPs was detected in the cytoplasm and entire nucleus. I) shows the merged images of G and H. 
Notes: green: FITc-conjugated hPNPs. red: propidium iodide permeation. Blue: nuclear staining by DAPI. scale bars: A–F = 100 μm, G–I = 10 μm.
Abbreviation: hPNPs, hyperbranched polylysine nanoparticles.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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that nanoparticles can enter the cytoplasm of cochlear cells, 
nuclear delivery remains problematic.20,28 HPNPs were 
detected in both the cytoplasm and nuclei of cochlear cells 
in primary cell culture, organotypic culture, and in vivo with 
intratympanic administration. The present results contrast 
with the results of an in vivo study performed in guinea pigs 
using HPNPs.28 Our explanation is that the nuclear entry of 
HPNPs is concentration-dependent; in the in vivo study, 
cochlear cells were exposed to much lower concentrations 
of HPNPs than in the in vitro study. The cells that are inte-
grated in the organ may behave differently from individual 
cells. Nuclear localization of HPNPs was intense in the round 
window membrane cells of rats, but was rarely observed 
in the cochlear cells. The different methods of delivering 
the HPNPs and the biological differences between rats and 
guinea pigs should also be considered as an explanation for 
our results.
Concentration-dependent toxicity occurred in the primary 
cochlear cell culture, and most of the cells died when treated 
with HPNPs at the concentration of 3.87 × 10−7 mol/L 
(10−6.4 mol/L), whereas the ED50 for HPNP-treated L929 cells 
was 10−6.2 mol/L. This finding indicated that certain cell types 
in primary cochlear cell cultures may be more vulnerable 
to HPNP treatment than L929 cells. Spiral ganglion cells 
died when treated with HPNPs at a concentration of 
9.7 × 10−8 mol/L, which further supported this hypothesis, 
because neurons are highly sensitive to hazardous substance 
exposure. It seems contradictory that dead cells take up the 
highest amount of nanoparticles (Figure 9, 10−5 mol/L HPNPs). 
Figure 5 Death of different cochlear cell populations was induced by hPNP internalization. A–F) Internalization of hPNPs by the cochlear hair cell. cytoplasmic vesicles 
and condensed homogenous nuclear distribution of hPNPs appeared in the outer hair cell incubated with 3.87 × 10−7 mol/L hPNPs (A–C) and inner hair cell incubated with 
5 × 10−6 mol/L hPNPs (D–F). Vesicles were observed in the hair bundles (arrows in A and C). Figures B and E showed the permeation of propidium iodide. G–I) spiral 
ganglion cell death was induced by hPNP internalization at a concentration of 9.7 × 10−8 mol/L (Arrow in G shows hPNPs in the neural soma of spiral ganglion cell). H) shows 
the permeation of propidium iodide. I) shows the merged images of G and H (Arrow: nerve fiber. Arrow head: nuclei of Schwann cell). J–M) The nucleus was compressed 
by hPNP vesicles, and propidium iodide permeated the nucleus when the cells were exposed to 3.87 × 10−7 mol/L hPNPs (arrows). M is the merged image. 
Notes: green: FITc-conjugated hPNPs. red: propidium iodide permeation. Blue: nuclear staining by DAPI. scale bars: A–C = 5 μm, D–F = 7.1 μm, G–M = 5 μm.
Abbreviation: hPNPs, hyperbranched polylysine nanoparticles.
Figure  6 A hPNP vesicle  pathway  from  the  cytoplasm towards the  nucleolin-
positive nucleolus was observed in the primary cochlear cell culture exposed to 
hPNPs (arrows in A and C). 
Notes: green: FITc-conjugated hPNPs. red: nucleolin. Blue: nuclear staining by 
DAPI. scale bar = 10 μm.
Abbreviation: hPNPs, hyperbranched polylysine nanoparticles.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Figure 7 Uptake of hPNPs in the cochlear organotypic culture. The tissues were incubated with 2.5 × 10−6 mol/L (A, B) and 1 × 10−5 mol/L (C, D) hPNPs for 24 hours. 
A and B are merged images of hPNPs, Myosin VIIA, and DAPI in the modiolus (A) and organ of corti (B). C) low magnification and D) higher magnification are merged 
images of hPNPs, F-actin, and DAPI in the lateral wall. 
Notes: green: FITc-conjugated hPNPs. red: Myosin VIIA (A, B), F-actin stained by TrITc-conjugated phalloidin (C, D). Blue: nuclear staining by DAPI. scale bars: 
A, C = 103.4 μm, B, D = 10 μm.
Abbreviation: hPNPs, hyperbranched polylysine nanoparticles.
Figure 8 Uptake of hPNPs in the cochlea 24 hours after round window membrane administration in an adult rat. A gelatin sponge was immersed in 10−3 mol/L hPNPs 
and placed on the round window membrane. A) Lateral view of reconstructed three-dimensional image of the round window membrane showing the gradient distribution 
of hPNPs; both condensed homogenous nuclear distribution of hPNPs (arrow head) and hPNP vesicles (arrow) were observed. B) Middle ear mucosal uptake of hPNPs. 
condensed homogenous nuclear distribution of hPNPs (arrow head) and hPNP vesicles (arrow) were detected. C) Perinuclear distribution of hPNPs was observed in 
the spiral ganglion cell (arrow). D) hPNPs were found in the organ of corti. cytoplasmic distribution of hPNPs was observed in the hair cells, and both cytoplasmic and 
perinuclear distribution of hPNPs was detected in the supporting (border) cells. E) Both cytoplasmic and nuclear distribution of hPNPs was detected in the stria marginal 
cells, the typical tight junctions of the stria marginal cells are shown using F-actin staining (arrow). F) Abundant HPNPs were observed in the spiral ligament fibrocytes.   
G) Abundant hPNPs were detected in the endothelium of the stapedial artery including the nuclear hPNP vesicles (arrow). 
Notes: green: FITc-conjugated hPNPs. red: F-actin stained by TrITc-conjugated phalloidin. Blue: nuclear staining by DAPI. scale bar = 10 μm.
Abbreviations: Bc, border cells; hPNPs, hyperbranched polylysine nanoparticles; Ihc, inner hair cell; Is, inner side of the round window membrane; Ohc, outer hair cell; 
Os, outer side of the round window membrane; 1, 2, 3: row 1, row 2, and row 3 of Ohc. International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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The fluorescence signal merely indicated fluorescence 
associated with material adhering to the bottom of the 
microtiter well. Microscopic inspection showed that the 
cells were damaged, which led to binding of the HPNPs to 
the DNA such that the nuclei were brightly labeled, which 
corresponded to a strong fluorescence signal. As a cell death 
indicator, the cochlear cells stained by propidium iodide had 
a dot-like appearance in the perinuclear region (Figure 3B) 
which was different from that reported in the literature.29 
It is obvious that the typical homogenous nuclear staining of 
propidium iodide indicated cell death. In primary cochlear 
cell cultures, higher concentrations of HPNPs incubation 
caused cell death (Figures 4 and 5). The dot-like perinuclear 
appearance of propidium iodide staining within the cochlear 
cells without nuclear staining suggested that these were viable 
cells (Figure 3B). The simultaneous nuclear distribution 
of HPNP vesicles and dot-like perinuclear appearance of 
propidium iodide (Figure 3B) also indicated active transport 
of HPNP in living cells. It should also be pointed out that 
HPNPs-containing vesicles are only detectable in living cells 
because passive diffusion of HPNPs into the nuclei following 
cell death will show homogenous distribution. As a result, 
nuclear entry of HPNPs was a meaningful biological process 
instead of a consequence of cell death.
Regarding the mechanism of nuclear import, there 
are potentially several pathways, such as nucleolin sig-
naling,   cellular membrane penetration, and the nuclear 
localization signal pathway, among others.30–33 One potential 
mechanism by which HPNPs mediate nuclear entry may be 
internalization and transport into the nucleus via binding to 
nucleolin.   Nucleolin is a ubiquitous eukaryotic protein that 
is conserved from yeast to mammals, and is found in the 
nucleoli, nucleoplasm, and on the cell surface.34,35 Nucleolin 
is able to shuttle between the plasma membrane, cytoplasm, 
and nucleus, and regulates many aspects of DNA and RNA 
metabolism.34,36 It has been reported that nucleolin is the 
cell surface target of DNA nanoparticles, and that nucleolin 
is essential for internalization and/or transport of the DNA 
nanoparticles from the cell surface to the nucleus.30 This 
was also indicated in our study, as demonstrated by the 
HPNP vesicle pathway from the cytoplasm towards the 
nucleolin-positive nucleolus (Figure 6). A recent report 
showed that nucleolin-mediated cellular trafficking of DNA 
nanoparticles is lipid raft- and microtubule-dependent, and 
can be modulated by glucocorticoids.37 Another potential 
mechanism is that the nuclear envelope penetration or fusion 
is potentially involved in the nuclear internalization of 
HPNPs by cochlear cells.25,33,38 It is possible that the HPNPs 
internalized within the cytoplasm are retained and tethered 
to the inner surface of the vesicle, and thereafter transported 
into the nuclei by molecular machinery (such as dyneins) 
along cytoskeletal tracks.33,38 Nuclear localization signal-
mediated nuclear transport of HPNPs is also a potential 
Figure  10  hPNP-mediated  transfection  in  NIh  3T3  cells  and  primary  cochlear  cells  with  the  pgeneclipTM  hMGFP  plasmid  observed  by  fluorescent  microscopy.   
A) The transfection efficiency mediated by HPNPs at an N/P (w/w) ratio of 5:1 in NIH 3T3 cells was 29.8%. B) The transfection efficiency mediated by HPNPs at an N/P 
(w/w) ratio of 5:1 in cochlear cells was 8.7%. C) Positive control, the transfection efficiency mediated by LipofectamineTM in cochlear cells was 6.0%, which is lower than the 
transfection efficiency mediated by HPNPs. 
Notes: green: Green fluorescent protein expression. Blue: nuclear staining by DAPI. Scale bar = 100 μm.
Abbreviation: hPNPs, hyperbranched polylysine nanoparticles.
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Figure  9  The  cell  viability  of  L929  mouse  fibroblasts  is  dependent  on  the 
concentration of hPNPs applied. The eD50 was calculated as 10−6.2 mol/L (dashed line). 
The internalization of the hPNPs is also concentration-dependent.
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mechanism, which requires the presence of cytosolic factors 
and adenosine triphosphate.39,40 We cannot rule out the pos-
sibility that HPNPs bind to specific cytosolic proteins in 
the primary newborn rat cochlea cells and pass through the 
nuclear pore complex. However, the present study did not 
prove or disprove this hypothesis.
Finally, the internalization of HPNPs by the cochlear cells 
was not specific for any cellular population. This did not meet 
our goal of targeted gene delivery into the cochlea. However, 
the functionalization of HPNPs with specific peptides for 
a definite cell population of the cochlea may improve the 
targetability of these nanoparticles. Specific targeting and 
higher binding affinity to spiral ganglion neurons has been 
observed in PEGylated polysome nanoparticles functional-
ized by a neurotrophin-derived peptide.41 HPNPs can also be 
included in other nanoparticles, such as lipid nanoparticles, 
to achieve both ideal targetability and efficient gene expres-
sion in cochlear cells.
Conclusion
In conclusion, efficient internalization of HPNPs was observed 
in both the cytoplasm and nucleus of cochlear cell culture, 
cochlear organotypic culture, and in vivo round window 
membranes. High transfection efficiencies were achieved in 
HPNP-mediated gene transfer in NIH 3T3 cells. These suggest 
that HPNPs have a potential application in gene delivery to 
the cochlea. To pass through the round window membrane 
and deliver genes into the cochlea efficiently, it is necessary 
to modify the nanoparticle surface to avoid early nuclear entry 
into the cells of the round window membrane.
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